Century Therapeutics, Inc. (IPSC)
NASDAQ
Market Cap
$207.87M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
621 of 809
Rank in Industry
341 of 445
Largest Insider Buys in Sector
IPSC Stock Price History Chart
IPSC Stock Performance
About Century Therapeutics, Inc.
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.
Insider Activity of Century Therapeutics, Inc.
Over the last 12 months, insiders at Century Therapeutics, Inc. have bought $0 and sold $371,718 worth of Century Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Century Therapeutics, Inc. have bought $32M and sold $4.04M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 100,000 shares for transaction amount of $2M was made by Versant Venture Capital VI, L.P. (10 percent owner) on 2021‑06‑22.
List of Insider Buy and Sell Transactions, Century Therapeutics, Inc.
| 2024-06-20 | Sale | Russotti Gregory | See Remarks | 5,000 0.0052% | $2.84 | $14,179 | -0.37% | |
| 2024-06-05 | Sale | Russotti Gregory | See Remarks | 5,000 0.006% | $3.00 | $14,989 | +1.34% | |
| 2024-05-20 | Sale | Russotti Gregory | See Remarks | 5,000 0.006% | $3.00 | $14,978 | +1.85% | |
| 2024-05-06 | Sale | Russotti Gregory | See Remarks | 5,000 0.0076% | $3.12 | $15,619 | -3.47% | |
| 2024-05-03 | Sale | Carr Douglas | SVP Finance & Operations | 257 0.0004% | $3.11 | $798 | +1.32% | |
| 2024-05-03 | Sale | Farid Adrienne | Chief Operations Officer | 913 0.0014% | $3.11 | $2,836 | +1.32% | |
| 2024-04-22 | Sale | Russotti Gregory | See Remarks | 5,000 0.0078% | $3.10 | $15,490 | -1.29% | |
| 2024-03-07 | Sale | Farid Adrienne | Chief Operations Officer | 22,831 0.0373% | $5.14 | $117,342 | -40.79% | |
| 2024-03-06 | Sale | Farid Adrienne | Chief Operations Officer | 30,684 0.0503% | $4.96 | $152,340 | -37.00% | |
| 2024-02-16 | Sale | Farid Adrienne | Chief Operations Officer | 485 0.0008% | $4.86 | $2,358 | -30.64% | |
| 2024-02-06 | Sale | Carr Douglas | SVP Finance & Operations | 557 0.001% | $4.49 | $2,499 | -26.70% | |
| 2024-02-06 | Sale | Farid Adrienne | Chief Operations Officer | 1,784 0.0031% | $4.49 | $8,005 | -26.70% | |
| 2024-02-05 | Sale | Carr Douglas | SVP Finance & Operations | 643 0.0009% | $3.84 | $2,470 | -17.08% | |
| 2024-02-05 | Sale | Farid Adrienne | Chief Operations Officer | 2,035 0.003% | $3.84 | $7,816 | -17.08% | |
| 2023-03-23 | Sale | Borges Luis | Chief Scientific Officer | 15,597 0.0271% | $3.55 | $55,369 | -11.53% | |
| 2023-03-22 | Sale | Borges Luis | Chief Scientific Officer | 65,698 0.1172% | $3.72 | $244,640 | -13.20% | |
| 2023-03-21 | Sale | Borges Luis | Chief Scientific Officer | 63,616 0.1088% | $3.77 | $239,870 | -17.82% | |
| 2022-08-09 | Sale | Versant Vantage II GP-GP, LLC | 550,000 0.9437% | $13.03 | $7.17M | -65.23% | ||
| 2021-06-22 | BAYER AKTIENGESELLSCHAFT | 10 percent owner | 750,000 4.8121% | $20.00 | $15M | -41.00% | ||
| 2021-06-22 | Casdin Eli | director | 750,000 4.8121% | $20.00 | $15M | -41.00% |
Insider Historical Profitability
<0.0001%
| Carr Douglas | SVP Finance & Operations | 317323 0.5074% | $2.46 | 0 | 3 | |
| Russotti Gregory | See Remarks | 277319 0.4579% | $2.46 | 0 | 5 | |
| Farid Adrienne | Chief Operations Officer | 137236 0.1908% | $2.46 | 0 | 6 | |
| BAYER AKTIENGESELLSCHAFT | 10 percent owner | 12675838 21.1847% | $2.46 | 1 | 0 | <0.0001% |
| Versant Vantage II GP-GP, LLC | 11816814 19.749% | $2.46 | 0 | 1 | ||
| Casdin Eli | director | 3206380 5.3587% | $2.46 | 1 | 0 | <0.0001% |
| Versant Venture Capital VI, L.P. | 10 percent owner | 714095 1.1934% | $2.46 | 1 | 0 | <0.0001% |
| Borges Luis | Chief Scientific Officer | 249083 0.4163% | $2.46 | 0 | 3 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Vr Adviser Llc | $14.23M | 4.09 | 3.41M | New | +$14.23M | 0.69 | |
| Fidelity Investments | $14.09M | 4.05 | 3.37M | -6.68% | -$1.01M | <0.01 | |
| Casdin Capital | $13.4M | 3.86 | 3.21M | 0% | +$0 | 1 | |
| Boxer Capital, LLC | $7.32M | 2.1 | 1.75M | New | +$7.32M | 0.37 | |
| BlackRock | $6.26M | 1.8 | 1.5M | -1.37% | -$87,006.71 | <0.0001 | |
| DAFNA Capital Management, LLC | $5.46M | 1.57 | 1.31M | 0% | +$0 | 1.27 | |
| Avidity Partners Management Lp | $5.11M | 1.47 | 1.22M | -9.85% | -$557,800.11 | 0.19 | |
| The Vanguard Group | $4.76M | 1.37 | 1.14M | +1.25% | +$58,520.01 | <0.0001 | |
| Tang Capital Management, LLC | $3.76M | 1.08 | 900,000 | -15.61% | -$695,719.20 | 0.02 | |
| Baker Bros Advisors LP | $3.33M | 0.96 | 797,460 | 0% | +$0 | 0.04 | |
| Federated Hermes | $2.57M | 0.74 | 615,143 | -0.54% | -$13,957.02 | 0.01 | |
| Octagon Capital Advisors LP | $2.26M | 0.65 | 540,000 | New | +$2.26M | 0.3 | |
| Geode Capital Management | $2.13M | 0.61 | 510,591 | +8.99% | +$176,139.40 | <0.0001 | |
| State Street | $2.03M | 0.58 | 485,218 | +8.19% | +$153,518.84 | <0.0001 | |
| Millennium Management LLC | $1.49M | 0.43 | 357,401 | +157.2% | +$913,083.27 | <0.01 | |
| Jacobs Levy Equity Management | $1.23M | 0.35 | 293,941 | +190.96% | +$806,384.45 | 0.01 | |
| Morgan Stanley | $896,109.00 | 0.26 | 214,380 | -23.42% | -$273,990.82 | <0.0001 | |
| Northern Trust | $771,691.00 | 0.22 | 184,615 | -0.73% | -$5,701.52 | <0.0001 | |
| Renaissance Technologies | $652,000.00 | 0.19 | 156,000 | +30.87% | +$153,805.13 | <0.01 | |
| Charles Schwab | $635,573.00 | 0.18 | 152,051 | +2.21% | +$13,752.20 | <0.0001 | |
| Bridgeway Capital Management | $491,568.00 | 0.14 | 117,600 | -2.08% | -$10,450.00 | 0.01 | |
| Schonfeld Group | $389,095.00 | 0.11 | 93,085 | New | +$389,095.00 | <0.01 | |
| Wealth Enhancement Advisory Services LLC | $326,939.00 | 0.09 | 78,215 | 0% | +$0 | <0.01 | |
| BNY Mellon | $296,412.00 | 0.09 | 70,912 | -21.69% | -$82,111.88 | <0.0001 | |
| Nuveen | $250,963.00 | 0.07 | 60,039 | 0% | +$0 | <0.0001 | |
| Citadel Advisors LLC | $226,940.00 | 0.07 | 54,292 | -45.66% | -$190,720.39 | <0.0001 | |
| Cornercap Investment Counsel Inc | $215,354.00 | 0.06 | 51,520 | 0% | +$0 | 0.03 | |
| Bank of America | $176,993.00 | 0.05 | 42,343 | -1.27% | -$2,282.27 | <0.0001 | |
| Goldman Sachs | $164,203.00 | 0.05 | 39,283 | -11.97% | -$22,329.57 | <0.0001 | |
| RhumbLine Advisers | $140,595.00 | 0.04 | 33,638 | +2.1% | +$2,892.32 | <0.0001 | |
| Dimensional Fund Advisors | $130,249.00 | 0.04 | 31,160 | -4.41% | -$6,010.85 | <0.0001 | |
| UBS | $120,041.00 | 0.04 | 28,718 | +12.21% | +$13,062.47 | <0.0001 | |
| HarbourVest Partners | $121,295.00 | 0.04 | 29,018 | 0% | +$0 | 0.06 | |
| Parametrica Management Ltd | $116,371.00 | 0.03 | 27,840 | 0% | +$0 | 0.17 | |
| JPMorgan Chase | $107,342.00 | 0.03 | 25,680 | +69.15% | +$43,881.48 | <0.0001 | |
| Jump Financial Llc | $93,339.00 | 0.03 | 22,330 | New | +$93,339.00 | <0.01 | |
| Cubist Systematic Strategies | $79,031.00 | 0.02 | 18,907 | New | +$79,031.00 | <0.01 | |
| Barclays | $69,000.00 | 0.02 | 16,463 | -48.85% | -$65,890.12 | <0.0001 | |
| New York State Common Retirement Fund | $57,000.00 | 0.02 | 13,743 | -0.21% | -$120.28 | <0.0001 | |
| Occudo Quantitative Strategies Lp | $56,689.00 | 0.02 | 13,562 | New | +$56,689.00 | 0.01 | |
| Jane Street Capital | $51,038.00 | 0.02 | 12,210 | -30.97% | -$22,893.95 | <0.0001 | |
| American International Group | $48,250.00 | 0.01 | 11,543 | -0.86% | -$418.00 | <0.0001 | |
| Prudential Financial | $49,408.00 | 0.01 | 11,820 | New | +$49,408.00 | <0.0001 | |
| AllianceBernstein | $48,404.00 | 0.01 | 11,580 | 0% | +$0 | <0.0001 | |
| Mirae Asset Global Investments Co Ltd | $38,510.00 | 0.01 | 11,130 | New | +$38,510.00 | <0.0001 | |
| Founders Financial Securities | $41,800.00 | 0.01 | 10,000 | 0% | +$0 | 0.01 | |
| Deutsche Bank | $40,688.00 | 0.01 | 9,734 | -65.83% | -$78,404.03 | <0.0001 | |
| Wells Fargo | $34,539.00 | 0.01 | 8,263 | +14.72% | +$4,430.76 | <0.0001 | |
| Citigroup | $19,211.00 | 0.01 | 4,596 | +30.64% | +$4,505.97 | <0.0001 | |
| Tower Research Capital | $18,208.00 | 0.01 | 4,356 | +10.28% | +$1,697.07 | <0.0001 |